RAF1 and RASopathy: The discovery of germline mutations in RAS and in genes encoding other proteins involved in Raf/MEK/ERK (MAPK) signaling delineated dysregulation of this pathway as a unifying mechanism underlying the RASopathy disorders and uncovered a key role of MAPK activation in regulating cell fate decisions in multiple developing tissues (1–3).